Building GCCs Sustainable Cell & Gene Therapy Ecosystem: From Research to Real-World Impact

Building a fully integrated cell and gene therapy ecosystem is one of the most complex challenges facing emerging biotech markets today. But translating academic research into scalable, sustainable infrastructure is even harder. Saudi Arabia is rapidly emerging as a leader in building a fully integrated cell and gene therapy ecosystem, connecting research, clinical development, and manufacturing into a coordinated national strategy. But turning scientific excellence into scalable, real-world impact requires more than investment; it demands alignment across every layer of the ecosystem. With strong foundations already in place, from world-class research institutions to growing GMP and manufacturing capabilities, the Kingdom is uniquely positioned to accelerate the development and delivery of advanced therapies. The focus is no longer just on innovation, but on enabling that innovation to reach patients at scale. This session will explore: - A clear understanding of how Saudi Arabia is structuring its end-to-end CGT ecosystem; from research through to commercial manufacturing - Insight into the practical steps required to move from academic innovation to scalable infrastructure - Real examples of how biotech hubs like Boston, Ireland and China connected GMP facilities, research institutions, and clinical centres. Join leading voices of who built ecosystems and how Saudi Arabia can turn strategy into execution.